“Arrhythmia-induced cardiomyopathy (AIC)” is a reversible form of heart muscle damage that results from chronic or sustained arrhythmias. AIC is a relatively rare condition that can lead to significant morbidity and mortality if left untreated. This review article aims to provide a comprehensive overview of the current knowledge on AIC, including its definition, mechanisms, prevalence, clinical features, diagnosis, management, prognosis, and future directions. AIC is characterized by structural and functional changes in the heart muscle due to chronic or sustained arrhythmias. The underlying mechanisms involve a complex interplay of electrical and mechanical factors that lead to myocardial remodeling and dysfunction. The clinical presentation of AIC can vary widely, and a high index of suspicion is necessary for timely diagnosis. Management strategies include controlling the underlying arrhythmia, optimizing heart failure treatment, and considering implantable cardiac devices. Prognosis is generally good if the underlying arrhythmia is successfully treated and left ventricular function improves. AIC is an important and often underrecognized cause of reversible cardiomyopathy. Early recognition, prompt diagnosis, and appropriate management are crucial to prevent irreversible heart damage and improve clinical outcomes. Further research is needed to improve our understanding of the pathophysiology of AIC and to develop more effective management strategies.